These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 512353)

  • 1. HLA antigens and responses to rubella vaccination.
    Harcourt GC; Best JM; Banatvala JE; Kennedy LA
    J Hyg (Lond); 1979 Dec; 83(3):405-12. PubMed ID: 512353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Japanese rubella vaccine: comparative trials.
    Best JM; Banatvala JE; Bowen JM
    Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with clinical reactions to rubella vaccination in women.
    Nakazono N; Fujimoto S; Wakisaka A; Ishii K; Ichinoe K; Aizawa M
    Int J Gynaecol Obstet; 1987 Jun; 25(3):207-16. PubMed ID: 2886379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and the rubella-specific immune response following vaccination.
    Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
    Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines.
    Buimovici-Klein E; Cooper LZ
    Infect Immun; 1979 Jul; 25(1):352-6. PubMed ID: 478639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.
    Al-Nakib W; Best JM; Banatvala JE
    Clin Exp Immunol; 1975 Nov; 22(2):293-301. PubMed ID: 813933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.
    O'Shea S; Best JM; Banatvala JE; Shepherd WM
    J Infect Dis; 1985 Jan; 151(1):89-98. PubMed ID: 3965597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rubella vaccination in adult females.
    Weibel RE; Stokes J; Buynak EB; Hilleman MR
    N Engl J Med; 1969 Mar; 280(13):682-5. PubMed ID: 5250184
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to experimental challenge in persons immunized with different rubella vaccines.
    Fogel A; Gerichter CB; Barnea B; Handsher R; Heeger E
    J Pediatr; 1978 Jan; 92(1):26-9. PubMed ID: 619075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.
    Al-Nakib W; Best JM; Banatvala JE
    Lancet; 1975 Jan; 1(7900):182-5. PubMed ID: 47417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response in school children to live rubella vaccine (Cendehill strain).
    Iwakata S; Elkerton LE; Rhodes AJ; Bull JA; Labzoffsky NA
    Can Med Assoc J; 1972 May; 106(9):980-2. PubMed ID: 4554732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response following rubella immunization analyzed by HLA types.
    Ishii K; Nakazono N; Sawada H; Wakisaka A; Moriuchi J; Nakai Y; Kano T; Aizawa M
    Jpn J Med Sci Biol; 1980 Apr; 33(2):103. PubMed ID: 7412020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunologic marker technique for the Cendehill vaccine strain of rubella virus.
    Oxford JS; Potter CW
    J Immunol; 1970 Oct; 105(4):818-23. PubMed ID: 5470523
    [No Abstract]   [Full Text] [Related]  

  • 20. Host factors and susceptibility to rubella virus infection: the association of HLA antigens.
    Ishii K; Nakazono N; Sawada H; Fukuda K; Wakisaka A; Moriuchi J; Nakai Y; Kano T; Aizawa M
    J Med Virol; 1981; 7(4):287-97. PubMed ID: 6950026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.